Bilastin-Mepha Allergie lingual 20 mg
Bilastin-Mepha Allergie lingual 20 mg is a medicine authorised by Swissmedic under authorisation number 69558. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 16 March 2025 and the authorisation is limited until 15 March 2030. ATC code R06AX29 places the medicine in the group Antihistamines for systemic use.
| Authorisation number | 69558 |
|---|---|
| Name | Bilastin-Mepha Allergie lingual 20 mg |
| Full name | Bilastin-Mepha Allergie lingual 20 mg, Schmelztablette |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R06AX29 |
| First authorisation | 16 March 2025 |
| Authorisation validity | 15 March 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bilastin-Mepha Allergie lingual 20 mg, Schmelztablette | D | 16 March 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | R06AX29 | 07.13.1. | D |
| 2 | 30 | Tablette(n) | R06AX29 | 07.13.1. | D |
| 3 | 50 | Tablette(n) | R06AX29 | 07.13.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bilastin-Mepha Allergie lingual 20 mg authorised in Switzerland?
Yes. Bilastin-Mepha Allergie lingual 20 mg is authorised by Swissmedic under authorisation number 69558, data as of 01 September 2026. The authorisation is limited until 15 March 2030.
Which dispensing category does Bilastin-Mepha Allergie lingual 20 mg have?
Bilastin-Mepha Allergie lingual 20 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Bilastin-Mepha Allergie lingual 20 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.